// App-Quantinova.ai

TCT-412 : Long-term clinical outcomes after implantation of everolimus-eluting bioresorbable vascular scaffold in patients with acute myocardial infarction. 24-month clinical follow-up of the BVS STEMI First Study

Researchers

Presenter

  • Mariusz Tomaniak

Principal Investigators

  • Jiang Ming Fam

  • Cordula Felix

  • Robert-Jan van Geuns

  • Nicolas Van Mieghem

  • Evelyn Regar

  • Joost Daemen

  • Felix Zijlstra

  • Roberto Diletti

Medical Centers

  • Thoraxcenter, Erasmus Medical Center, Rotterdam, Rotterdam, Netherlands

  • Thoraxcenter, Erasmus MC, Rotterdam, Netherlands

  • ThoraxCenter, Erasmus MC, Rotterdam, The Netherlands, Medical University of Warsaw, Warsaw, Poland

  • Erasmus University Medical Center, Rotterdam, Netherlands

Locations

  • Poland

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved